NRG-BN009
Terminated
Protocol Information
Tab containing protocol details, study design, and eligibility criteria
Tab containing study documents, informed consent forms, and study materials
Tab containing information for potential study participants
Phase III Trial of Stereotactic Radiosurgery (SRS) or Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) for Distant Brain Relapse with Brain Metastasis Velocity >/= 4 Brain Metastases/Year
Principal Investigator
Status
Terminated
Open to Accrual
December 15, 2020
Closed to Accrual
August 6, 2024
Closed to Accrual & Treatment
August 6, 2024
Terminated
August 6, 2024
Disease Site
Brain [BN] Other
Phase
III
Developmental Therapeutics
No
Primary Objective
To determine if hippocampal-avoidant whole brain radiotherapy (HA-WBRT) in patients with distant brain failure with brain metastasis velocity ≥4 new brain metastases/year prolongs time to neurologic death as compared to stereotactic radiosurgery (SRS).
Patient Population
Distant brain relapse with brain metastasis velocity ≥4 brain metastases/year since last SRS
Target Accrual
350
Protocol Documents
Available via the National Cancer Institute (NCI) Cancer Trials Support Unit (CTSU) website.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.
-
Share this study.
-
-
-
-
